BioRegenx, Inc.
BRGX
$0.0129
$0.001917.27%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -18.80% | 33.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.80% | 33.58% | |||
| Cost of Revenue | -56.70% | 59.73% | |||
| Gross Profit | 2.49% | 22.31% | |||
| SG&A Expenses | -73.94% | -68.05% | |||
| Depreciation & Amortization | 0.00% | 12.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.95% | -51.12% | |||
| Operating Income | 68.52% | 66.23% | |||
| Income Before Tax | 64.30% | 64.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 64.30% | 64.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 64.30% | 64.91% | |||
| EBIT | 68.52% | 66.23% | |||
| EBITDA | 245.75% | 94.11% | |||
| EPS Basic | 66.67% | 63.64% | |||
| Normalized Basic EPS | 57.14% | 66.67% | |||
| EPS Diluted | 66.67% | 63.64% | |||
| Normalized Diluted EPS | 57.14% | 66.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
